QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
LON:BTG

BTG - BTG Share Forecast, Price & News

GBX 840
+1.00 (+0.12%)
(As of 08/19/2019)
Add
Compare
Today's Range
840
840
50-Day Range
840
840
52-Week Range
512.50
853
Volume
271,742 shs
Average Volume
960,389 shs
Market Capitalization
£3.26 billion
P/E Ratio
29.47
Dividend Yield
N/A
Price Target
N/A

BTG stock logo

About BTG (LON:BTG) Stock

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

Receive BTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

BTG Stock News Headlines

BTG/KRW - Bitcoin Gold Korean Won
BTG/SAR - Bitcoin Gold Saudi Riyal
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Analysts Expect IGE Will Reach $46 - Nasdaq
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
BTG/USD OKX Technical Analysis
BTG Pactual presents the Mynt crypto asset platform
See More Headlines
Receive BTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

BTG Company Calendar

Last Earnings
5/15/2018
Today
3/29/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
1,631
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£914.10 million
Cash Flow
GBX 90.80 per share
Book Value
GBX 355.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.26 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Dr. Louise Makin MA (Age 58)
    Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director
  • Mr. Duncan Kennedy A.C.A.
    B.Sc., CFO & Director
  • Dr. Peter Stratford (Age 52)
    Chief Technical Officer & Head of Innovation
  • Mr. Andy Burrows
    VP of Corp. & Investor Relations
  • Dr. Paul Mussenden
    Gen. Counsel, Head of Strategic Affairs & Company Sec.













BTG Stock - Frequently Asked Questions

How have BTG shares performed in 2023?

BTG's stock was trading at GBX 840 at the start of the year. Since then, BTG stock has increased by 0.0% and is now trading at GBX 840.
View the best growth stocks for 2023 here
.

How were BTG's earnings last quarter?

BTG plc (LON:BTG) announced its quarterly earnings results on Tuesday, May, 15th. The company reported $32.90 EPS for the quarter, beating the consensus estimate of $29.80 by $3.10.

What other stocks do shareholders of BTG own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Vectura Group (VEC), Bank of America (BAC), B2Gold (BTO), Serco Group (SRP), Tahoe Resources (TAHO) and Advanced Micro Devices (AMD).

What is BTG's stock symbol?

BTG trades on the London Stock Exchange (LON) under the ticker symbol "BTG."

How do I buy shares of BTG?

Shares of BTG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is BTG's stock price today?

One share of BTG stock can currently be purchased for approximately GBX 840.

How much money does BTG make?

BTG (LON:BTG) has a market capitalization of £3.26 billion and generates £914.10 million in revenue each year.

How many employees does BTG have?

The company employs 1,631 workers across the globe.

How can I contact BTG?

BTG's mailing address is 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom. The official website for the company is www.btgplc.com. The company can be reached via phone at +44-20-75750000.

This page (LON:BTG) was last updated on 3/29/2023 by MarketBeat.com Staff